Franklin Joseph Zieve MD
Associate Professor, Internal Medicine, Virginia Commonwealth University, Medical College of Virginia School of Medicine. Preventative Cardiology
Join to View Full Profile
1201 Broad Rock BlvdHunter Holmes Mcguire Va Medical CenterRichmond, VA 23249
Phone+1 804-675-5151
Fax+1 804-675-5139
Dr. Zieve is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MinnesotaResidency, Internal Medicine, 1974 - 1975- University of MinnesotaInternship, Internal Medicine, 1971 - 1972
- University of Minnesota Medical SchoolClass of 1971
Certifications & Licensure
VA State Medical License 1979 - 2026
MN State Medical License 1972 - 1983
American Board of Internal Medicine Internal Medicine
Clinical Trials
- VA NEPHRON-D: Diabetes iN Nephropathy Study Start of enrollment: 2008 Jul 01
- Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease Start of enrollment: 2013 Mar 18
Publications & Presentations
PubMed
- 12 citationsEfficacy and safety of alirocumab in statin-intolerant patients over 3 years: open-label treatment period of the ODYSSEY ALTERNATIVE trial.Patrick M. Moriarty, Paul D. Thompson, Christopher P. Cannon, John R. Guyton, Jean Bergeron
Journal of Clinical Lipidology. 2020-01-01 - 351 citationsEfficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trialPatrick M. Moriarty, Paul D. Thompson, Christopher P. Cannon, John R. Guyton, Jean Bergeron
Journal of Clinical Lipidology. 2015-11-01 - 17 citationsAtorvastatin 10 mg plus ezetimibe versus titration to atorvastatin 40 mg: attainment of European and Canadian guideline lipid targets in high-risk subjects ≥65 yearsChristian Constance, Ori Ben-Yehuda, Nanette K. Wenger, Franklin J. Zieve, Jianxin Lin
Lipids in Health and Disease. 2014-01-13
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
